François Eyskens

Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

Derralynn Hughes, Suma P. Shankar, Gere Sunder–Plassmann et al. · Journal of Medical Genetics · 2016 · 386 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Belgian Fabry Study

Raf Brouns, Vincent Thijs, François Eyskens et al. · Stroke · 2010 · 114 citations · Full text

Life Sciences, Genetics, Neurology +15

Multiplex ligation‐dependent probe amplification to detect subtelomeric rearrangements in routine diagnostics

Liesbeth Rooms, Edwin Reyniers, Wim Wuyts et al. · Clinical Genetics · 2005 · 69 citations

Medicine, Genetics, Molecular Genetics +15

Middelheim Fabry Study (MiFaS): A retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke

Raf Brouns, Rishi Sheorajpanday, Ellen Braxel et al. · Clinical Neurology and Neurosurgery · 2007 · 65 citations

Medicine, Clinical Sciences, Neurology +6

Dietary management of urea cycle disorders: European practice

Sarah Adam, Manuela Almeida, Murielle Assoun et al. · Molecular Genetics and Metabolism · 2013 · 53 citations

Agriculture, Nephrology, Nutrition +12